BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 24533869)

  • 1. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy.
    Hwang I; Lee JM; Lee KB; Yoon JH; Kiefer B; Han JK; Choi BI
    Radiology; 2014 Jun; 271(3):730-8. PubMed ID: 24533869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.
    van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J
    Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Use of MR Fat Quantification and MR Elastography in Living Liver Donors: Can It Reduce the Need for Preoperative Liver Biopsy?
    Yoon JH; Lee JM; Suh KS; Lee KW; Yi NJ; Lee KB; Han JK; Choi BI
    Radiology; 2015 Aug; 276(2):453-64. PubMed ID: 25763828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.
    Guiu B; Petit JM; Loffroy R; Ben Salem D; Aho S; Masson D; Hillon P; Krause D; Cercueil JP
    Radiology; 2009 Jan; 250(1):95-102. PubMed ID: 19092092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities.
    Guaraldi G; Besutti G; Stentarelli C; Zona S; Nocetti L; Loria P; Ballestri S; Losi L; Torricelli P; Ligabue G
    Antivir Ther; 2012; 17(6):965-71. PubMed ID: 22766513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.
    Kang BK; Yu ES; Lee SS; Lee Y; Kim N; Sirlin CB; Cho EY; Yeom SK; Byun JH; Park SH; Lee MG
    Invest Radiol; 2012 Jun; 47(6):368-75. PubMed ID: 22543969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques.
    Wu CH; Ho MC; Jeng YM; Hsu CY; Liang PC; Hu RH; Lai HS; Shih TT
    J Gastroenterol Hepatol; 2014 Apr; 29(4):807-13. PubMed ID: 24224538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Gd-EOB-DTPA on hepatic fat quantification using high-speed T2-corrected multi-echo acquisition in (1)H MR spectroscopy.
    Park YS; Lee CH; Kim JH; Kim BH; Kim JH; Kim KA; Park CM
    Magn Reson Imaging; 2014 Sep; 32(7):886-90. PubMed ID: 24853467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.
    Lee SW; Park SH; Kim KW; Choi EK; Shin YM; Kim PN; Lee KH; Yu ES; Hwang S; Lee SG
    Radiology; 2007 Aug; 244(2):479-85. PubMed ID: 17641368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive quantification of hepatic steatosis in living, related liver donors using dual-echo Dixon imaging and single-voxel proton spectroscopy.
    Krishan S; Jain D; Bathina Y; Kale A; Saraf N; Saigal S; Choudhary N; Baijal SS; Soin A
    Clin Radiol; 2016 Jan; 71(1):58-63. PubMed ID: 26555703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment.
    Park SH; Kim PN; Kim KW; Lee SW; Yoon SE; Park SW; Ha HK; Lee MG; Hwang S; Lee SG; Yu ES; Cho EY
    Radiology; 2006 Apr; 239(1):105-12. PubMed ID: 16484355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging--correlation with histopathologic findings.
    Kim SH; Lee JM; Han JK; Lee JY; Lee KH; Han CJ; Jo JY; Yi NJ; Suh KS; Shin KS; Jo SY; Choi BI
    Radiology; 2006 Jul; 240(1):116-29. PubMed ID: 16684918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of hepatic steatosis: a comparison of computed tomography and magnetic resonance indices in candidates for living liver donation.
    Maruzzelli L; Parr AJ; Miraglia R; Tuzzolino F; Luca A
    Acad Radiol; 2014 Apr; 21(4):507-13. PubMed ID: 24594420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study.
    Bastati N; Feier D; Wibmer A; Traussnigg S; Balassy C; Tamandl D; Einspieler H; Wrba F; Trauner M; Herold C; Ba-Ssalamah A
    Radiology; 2014 Jun; 271(3):739-47. PubMed ID: 24576046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice?
    Parente DB; Rodrigues RS; Paiva FF; Oliveira Neto JA; Machado-Silva L; Lanzoni V; Campos CF; Eiras-Araujo AL; do Brasil PE; Garteiser P; Gomes MB; de Mello Perez R
    PLoS One; 2014; 9(11):e112574. PubMed ID: 25426708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Spectroscopy in Living-Donor Liver Transplantation.
    Chiang HJ; Chang WP; Chiang HW; Lazo MZ; Chen TY; Ou HY; Tsang LL; Huang TL; Chen CL; Cheng YF
    Transplant Proc; 2016 May; 48(4):1003-6. PubMed ID: 27320542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of hepatic macrosteatosis in living, related liver donors using T1-independent, T2*-corrected chemical shift MRI.
    Joe E; Lee JM; Kim KW; Lee KB; Kim SJ; Baek JH; Shin CI; Suh KS; Yi NJ; Han JK; Choi BI
    J Magn Reson Imaging; 2012 Nov; 36(5):1124-30. PubMed ID: 22761083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.
    Yokoo T; Bydder M; Hamilton G; Middleton MS; Gamst AC; Wolfson T; Hassanein T; Patton HM; Lavine JE; Schwimmer JB; Sirlin CB
    Radiology; 2009 Apr; 251(1):67-76. PubMed ID: 19221054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.